AVNS (Avanos Medical, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by AVNS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | Lisa Egbuonu-Davis | Director | D | — | — |
| 2026-07-28 | PATRICK J OLEARY | Director | D | — | — |
| 2026-07-28 | Indrani Lall Franchini | Director | D | — | — |
| 2026-07-28 | Sigfrido Delgado | SVP, Operations | MIXED | — | — |
| 2026-07-28 | Scott Michael Galovan | SVP, Chief Financial Officer | MIXED | — | — |
| 2026-07-28 | Julie Ann Shimer | Director | D | — | — |
| 2026-07-28 | GARY BLACKFORD | Director | D | — | — |
| 2026-07-28 | David Pacitti | Chief Executive Officer | MIXED | — | — |
| 2026-05-12 | Julie Ann Shimer | Director | A | — | — |
| 2026-05-12 | PATRICK J OLEARY | Director | A | — | — |
| 2026-05-12 | Lisa Egbuonu-Davis | Director | A | — | — |
| 2026-05-12 | Indrani Lall Franchini | Director | A | — | — |
| 2026-05-12 | GARY BLACKFORD | Director | A | — | — |
| 2026-04-24 | Sigfrido Delgado | SVP, Operations | F | — | — |
| 2026-04-24 | Scott Michael Galovan | SVP, Chief Financial Officer | F | — | — |
| 2026-04-16 | David Pacitti | Chief Executive Officer | F | — | — |
| 2026-04-01 | Scott Michael Galovan | SVP, Chief Financial Officer | A | — | — |
| 2026-04-01 | Sigfrido Delgado | SVP, Operations | A | — | — |
| 2026-04-01 | David Pacitti | Chief Executive Officer | A | — | — |
| 2026-04-01 | Sigfrido Delgado | SVP, Operations | A | — | — |
| 2026-04-01 | David Pacitti | Chief Executive Officer | A | — | — |
| 2026-04-01 | Scott Michael Galovan | SVP, Chief Financial Officer | A | — | — |
| 2026-03-17 | Sigfrido Delgado | SVP, Operations | A | — | — |
| 2026-03-17 | David Pacitti | Chief Executive Officer | A | — | — |
| 2026-03-17 | Scott Michael Galovan | SVP, Chief Financial Officer | A | — | — |
| 2026-03-17 | John Joseph Hurley | Principal Accounting Officer | A | — | — |
| 2026-03-11 | Scott Michael Galovan | SVP, Chief Financial Officer | F | — | — |
| 2026-03-11 | John Joseph Hurley | Principal Accounting Officer | F | — | — |
| 2026-03-10 | John Joseph Hurley | Principal Accounting Officer | MIXED | — | — |
| 2026-03-10 | Scott Michael Galovan | SVP, Chief Financial Officer | MIXED | — | — |
| 2025-11-19 | Kerr Holbrook | SVP, Chief Commercial Officer | Sell | — | — |
| 2025-09-09 | John Joseph Hurley | Principal Accounting Officer | F | — | — |
| 2025-08-15 | GARY BLACKFORD | Director | Buy | — | — |
| 2025-05-14 | Michael Greiner | Former Interim CEO | F | — | — |
| 2025-04-24 | Mojirade James | SVP, General Counsel | A | — | — |
| 2025-04-24 | Sigfrido Delgado | SVP, Operations | A | — | — |
| 2025-03-11 | John Joseph Hurley | Principal Accounting Officer | A | — | — |
| 2025-03-11 | Sigfrido Delgado | SVP, Operations | A | — | — |
| 2025-03-11 | Michael Greiner | Interim CEO | A | — | — |
| 2025-03-11 | Mojirade James | SVP, General Counsel | A | — | — |
| 2025-03-11 | Kerr Holbrook | SVP, Chief Commercial Officer | A | — | — |
| 2025-03-10 | Michael Greiner | Interim CEO | F | — | — |
| 2025-03-10 | Kerr Holbrook | SVP, Chief Commercial Officer | MIXED | — | — |
| 2025-03-10 | John Joseph Hurley | Principal Accounting Officer | F | — | — |
| 2025-03-10 | Joseph Fralin Woody | — | F | — | — |
| 2025-03-10 | Mojirade James | SVP, General Counsel | F | — | — |
| 2025-03-06 | John Joseph Hurley | Principal Accounting Officer | MIXED | — | — |
| 2025-03-06 | Michael Greiner | Interim CEO | MIXED | — | — |
| 2025-03-06 | Mojirade James | SVP, General Counsel | MIXED | — | — |
| 2025-03-06 | Joseph Fralin Woody | — | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 402,776 | — |
| — | Former Interim CEO | 204,493 | — |
| — | SVP, General Counsel | 104,518 | — |
| — | SVP, Chief Commercial Officer | 85,026 | — |
| — | SVP, Operations | 54,886 | — |
| — | Director | 49,618 | — |
| — | Director | 33,396 | — |
| — | SVP, Chief Financial Officer | 31,479 | — |
| — | Director | 31,197 | — |
| — | SVP, Global Supply Chain | 30,197 | — |
| — | SVP, General Counsel | 30,135 | — |
| — | Director | 28,855 | — |
| — | SVP, GM Pain Franchise | 28,443 | — |
| — | Senior VP, International | 26,761 | — |
| — | Vice President - Controller | 25,261 | — |
| — | Director | 21,316 | — |
| — | Principal Accounting Officer | 13,592 | — |
| — | SVP - Global Supply Chain | 10,636 | — |
| — | President, Global Franchises | 3,134 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AVNS quote page; the site-wide leaderboard is on the insider transactions hub.